Status:

COMPLETED

Acute Exercise and the Cerebral Metabolic Response in Aging and Alzheimer's Disease

Lead Sponsor:

University of Kansas Medical Center

Collaborating Sponsors:

National Institute on Aging (NIA)

Conditions:

Healthy Aging

Alzheimer Disease

Eligibility:

All Genders

60+ years

Phase:

NA

Brief Summary

The overall goal is to characterize the acute exercise response as it relates to brain glucose metabolism in aging and Alzheimer's Disease (AD). The study team will also examine lactate metabolism, re...

Detailed Description

Aim 1: Compare the effects of acute, moderate intensity and acute, higher intensity exercise on cerebral glucose metabolism in nondemented (ND) elderly and AD subjects. ND (n=30) and AD (n=30) subject...

Eligibility Criteria

Inclusion

  • Age 60 and older
  • Stable medication doses (\>1month)
  • Post-menopausal
  • Diagnosis of either Nondemented (CDR 0) or Probable AD (CDR 0.5 or 1 only)

Exclusion

  • Inability to provide consent
  • Diagnosis of insulin-dependent (Type 1) Diabetes Mellitus
  • Recent ischemic heart disease (\<2 years)
  • Diagnosis of an clinically significant chronic disease including cardiovascular disease (CVD), other metabolic diseases (e.g., thyroid), cancer, human immunodeficiency virus (HIV), or acquired immunodeficiency syndrome
  • Excluded from or unable to complete an MRI scan
  • Any Neurological disorders that have the potential to impair cognition or brain metabolism (e.g., Parkinson's disease, stroke defined as a clinical episode with neuroimaging evidence in an appropriate area to explain the symptoms).
  • Clinically significant depressive symptoms that may impair cognition, abnormalities in B12, rapid plasma regain (RPR), or thyroid function that may impair cognition, use of psychoactive and investigational medications, and significant visual or auditory impairment

Key Trial Info

Start Date :

August 28 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 31 2023

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04299308

Start Date

August 28 2020

End Date

October 31 2023

Last Update

July 23 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Univeristy of Kansas Medical Center

Kansas City, Kansas, United States, 66160